Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.
How Fast Is The Plasmid DNA Manufacturing Market Expected to Grow Between 2025 And 2029?
The market for plasmid DNA manufacturing has seen significant growth recently, with its value predicted to increase from $2.34 billion in 2024 to $2.89 billion in 2025, indicating a compound annual growth rate (CAGR) of 23.6%. The reason for such growth in the historical period has been its wide range of applications, such as in industrial processes, creating genetically modified organisms, or in the production of monoclonal antibodies using plasmid DNA in cell lines. Moreover, it has been used extensively in international health initiatives, bioremediation, environmental applications, and microbiome studies.
The market for plasmid DNA manufacturing is predicted to experience a notable escalation in the coming years, expanding to an estimated$6.46 billion by 2029″ with a compound annual growth rate of 22.2%. Factors contributing to this projected growth during the forecasted timeframe include the mounting utilization of plasmid DNA in creating DNA vaccines for communicable diseases, an upward trend in adopting plasmid DNA for the creation of antibody-drug couplings, and targeted therapies. The plasmid DNA’s use in augmenting cancer treatment and progress in intellectual property also favour market growth. The forthcoming period is expected to reflect a surge in activities related to licensing agreements for plasmid DNA technologies, bespoke solutions, strategies to cut costs, high-capacity screening, and the evolution of scalable manufacturing solutions.
Download a free sample to assess the report’s scope and structure:
https://www.thebusinessresearchcompany.com/sample.aspx?id=15895&type=smp
How Are Key Drivers in the Industry Acting as Catalysts for the Growth of thePlasmid DNA Manufacturing Market?
The escalating approval of gene therapy is predicted to fuel the expansion of the plasmid DNA manufacturing market in the future. Gene therapy is a health treatment that involves altering an individual’s genes as a way to cure or prevent diseases. Owing to advancements in genetic engineering, increasing investment in R&D, successful clinical trials, and the rising incidence of genetic diseases, gene therapy is becoming increasingly adopted, showcasing its potential to provide permanent or long-term healing. Plasmid DNA production is a critical component of gene therapy as it generates the necessary vectors for transporting curative genes into cells, aiding in tackling genetic diseases. For example, the American Society of Gene & Cell Therapy, a non-profit medical and scientific organization in the US, reported a 10% growth in the number of gene therapies in Phase III clinical trials in Q3 2023, marking the first quarterly growth since Q3 2022. Hence, the rising approval of gene therapy is propelling the expansion of the plasmid DNA manufacturing market.
Which Segments in the Plasmid DNA Manufacturing Offer the Most Growth?
The plasmid dna manufacturingmarket covered in this report is segmented –
1) By Grade: Research And Development Grade; Good Manufacturing Practice (GMP) Grade
2) By Development Phase: Pre-Clinical Therapeutics; Clinical Therapeutics; Marketed Therapeutics
3) By Disease: Infectious Disease; Cancer; Genetic Disorder; Other Diseases
4) By Application: Deoxyribonucleic Acid (DNA) Vaccines; Cell And Gene Therapy; Immunotherapy; Other Applications
Subsegments:
1) By Research And Development Grade: Small-scale Plasmid DNA Production; Preclinical Research Plasmid DNA
2) By Good Manufacturing Practice (GMP) Grade: Clinical Trial Material Production; Commercial-Scale Plasmid DNA Production
Request customized data on this market:
https://www.thebusinessresearchcompany.com/customise?id=15895&type=smp
What Are the Fastest-Growing Geographies in the #How Are Key Drivers in the Industry Acting as Catalysts for the Growth of thePlasmid DNA Manufacturing Market?# Market?
North America was the largest region in the plasmid DNA manufacturing market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the plasmid DNA manufacturing market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
What Are the Current Market Growth and Trends in the Plasmid DNA Manufacturing Industry?
Leading companies within the plasmid DNA production market are innovating with sophisticated bioprocessing techniques to refine the effectiveness, scalability, and quality of plasmid DNA manufacture. These advancements aim to smooth out the production procedure, lower manufacturing expenses, and ensure the plasmid DNA satisfies rigorous regulatory benchmarks for therapeutic use. For example, Charles River Laboratories, a pharmaceutical company headquartered in the US, inaugurated the eXpDNA platform in January 2023. This platform was conceptualized for the competent creation and cleaning of premium plasmid DNA. This system employs state-of-the-art bioprocessing technologies, scalable manufacturing methods, and strict quality control checks to generate plasmid DNA that adheres to severe stipulations for therapeutic and clinical utilizations. The eXpDNA platform finds its extensive use in gene therapy, formation of DNA vaccines, and other biopharma applications requiring high yield, purity and steadiness.
View the full report here:
https://www.thebusinessresearchcompany.com/report/plasmid-dna-manufacturing-global-market-report
What Are the Key Elements That Define the Plasmid DNA Manufacturing Market?
Plasmid deoxyribonucleic acid (DNA) manufacturing refers to the process of producing large quantities of plasmid DNA molecules for use in various biotechnological applications, including gene therapy, molecular cloning, and the production of recombinant proteins. This process involves the growth of bacterial cells containing the desired plasmid DNA, followed by purification to isolate the plasmid DNA from other cellular components.
Purchase the full report and get a swift delivery:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=15895
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Europe +44 7882 955267
Asia & Others +44 7882 955267 & +91 8897263534
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model